MX2016013255A - Metodos y composiciones para detectar proteinas mal plegadas. - Google Patents

Metodos y composiciones para detectar proteinas mal plegadas.

Info

Publication number
MX2016013255A
MX2016013255A MX2016013255A MX2016013255A MX2016013255A MX 2016013255 A MX2016013255 A MX 2016013255A MX 2016013255 A MX2016013255 A MX 2016013255A MX 2016013255 A MX2016013255 A MX 2016013255A MX 2016013255 A MX2016013255 A MX 2016013255A
Authority
MX
Mexico
Prior art keywords
compositions
methods
misfolded proteins
detecting misfolded
pregnant woman
Prior art date
Application number
MX2016013255A
Other languages
English (en)
Inventor
Buhimschi Irina
S Buhimschi Catalin
CHOMA Michael
TAGARE Hemant
Michael JONAS Stephan
Original Assignee
Univ Yale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale filed Critical Univ Yale
Publication of MX2016013255A publication Critical patent/MX2016013255A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6827—Total protein determination, e.g. albumin in urine
    • G01N33/6839—Total protein determination, e.g. albumin in urine involving dyes, e.g. Coomassie blue, bromcresol green
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B69/00—Dyes not provided for by a single group of this subclass
    • C09B69/10—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds
    • C09B69/106—Polymeric dyes; Reaction products of dyes with monomers or with macromolecular compounds containing an azo dye
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/75—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated
    • G01N21/77—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator
    • G01N21/78—Systems in which material is subjected to a chemical reaction, the progress or the result of the reaction being investigated by observing the effect on a chemical indicator producing a change of colour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Reproductive Health (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Varios aspectos y modalidades de la presente descripción están dirigidos hacia métodos y composiciones (por ejemplo, kits) para la identificación de sujetos con proteínas mal plegadas en su orina; por ejemplo, se proveen métodos y composiciones para determinar que una muestra de orina de una mujer embarazada contiene o no contiene proteínas mal plegadas; en algunas modalidades, la presencia de proteínas mal plegadas en una muestra de orina de una mujer embarazada, es una indicación de preeclampsia.
MX2016013255A 2014-04-10 2015-04-10 Metodos y composiciones para detectar proteinas mal plegadas. MX2016013255A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461978158P 2014-04-10 2014-04-10
PCT/US2015/025432 WO2015157704A2 (en) 2014-04-10 2015-04-10 Methods and compositions for detecting misfolded proteins

Publications (1)

Publication Number Publication Date
MX2016013255A true MX2016013255A (es) 2017-05-03

Family

ID=54264908

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016013255A MX2016013255A (es) 2014-04-10 2015-04-10 Metodos y composiciones para detectar proteinas mal plegadas.
MX2021006791A MX2021006791A (es) 2014-04-10 2016-10-07 Metodos y composiciones para detectar proteinas mal plegadas.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021006791A MX2021006791A (es) 2014-04-10 2016-10-07 Metodos y composiciones para detectar proteinas mal plegadas.

Country Status (11)

Country Link
US (3) US10324094B2 (es)
EP (2) EP3745127B1 (es)
JP (1) JP6697394B2 (es)
CN (2) CN116027043A (es)
AU (3) AU2015243171B2 (es)
CA (2) CA2945058C (es)
DK (1) DK3129779T3 (es)
ES (1) ES2817417T3 (es)
MX (2) MX2016013255A (es)
WO (1) WO2015157704A2 (es)
ZA (1) ZA201606987B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105021821B (zh) 2008-10-31 2018-05-11 耶鲁大学 先兆子痫检测和治疗的方法和组合物
CN116027043A (zh) 2014-04-10 2023-04-28 耶鲁大学 检测错误折叠蛋白的方法和组合物
EP3322985B1 (en) 2015-07-15 2021-10-13 Gestvision, Inc. Device for detecting misfolded proteins and methods of use thereof
US11344121B2 (en) 2016-04-14 2022-05-31 The Texas A&M University System Methods of predicting preeclampsia using biomarkers
US10345244B2 (en) * 2016-06-03 2019-07-09 International Business Machines Corporation Diagnostic test device with patterned material spots
US10335045B2 (en) 2016-06-24 2019-07-02 Universita Degli Studi Di Trento Self-adaptive matrix completion for heart rate estimation from face videos under realistic conditions
US10269107B2 (en) * 2017-02-23 2019-04-23 Global Neighbor Inc Selective plant detection and treatment using green luminance photometric machine vision scan with real time chromaticity operations and image parameter floors for low processing load
AU2018345841A1 (en) 2017-10-06 2020-05-21 The Research Foundation For The State University For The State Of New York Selective optical aqueous and non-aqueous detection of free sulfites
WO2019128506A1 (zh) * 2017-12-28 2019-07-04 浙江数问生物技术有限公司 一种检测错误折叠蛋白质的装置、试剂盒和方法
US11255844B2 (en) * 2018-03-06 2022-02-22 Fresenius Medical Care Holdings, Inc. Peritoneal dialysis systems and related methods
CN109659011A (zh) * 2018-12-29 2019-04-19 杭州脉流科技有限公司 利用移动设备采集处理十二导联ecg图像的方法以及移动设备和计算机可读存储介质
US20240003909A1 (en) * 2020-11-21 2024-01-04 Xingmin Li Apparatus and method for detecting misfolded protein in biological sample
WO2023222136A1 (zh) * 2022-05-20 2023-11-23 数问生物技术（宣城）有限公司 用于检测生物样本中的错误折叠蛋白质的装置和系统
CN117236201B (zh) * 2023-11-16 2024-02-23 南京信息工程大学 一种基于Diffusion和ViT的降尺度方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US234610A (en) * 1880-11-16 Robert o
US4444879A (en) 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
WO1992017769A1 (en) * 1991-03-28 1992-10-15 Micro Research Inc. Controlled-release solid phase assay device including encapsulated reagents for detecting chemical substances
US5998216A (en) 1996-10-01 1999-12-07 Beth Israel Deaconess Medical Center Stabilizing formulation for preserving the integrity of proteins present in a body fluid sampled ex-vivo for evaluation as a specimen
EP0951298A1 (en) 1996-12-23 1999-10-27 Cambridge University Technical Services Limited Diagnosis and treatment of pathological pregnancies
US6444435B1 (en) * 2000-11-30 2002-09-03 Serim Research Corporation Test strip for determining dialysate composition
US7355044B2 (en) 2001-10-25 2008-04-08 Agfa-Gevaert N.V. Self-assembling dyes
EA200500232A1 (ru) 2002-07-19 2005-12-29 Бет Изрейэл Диконисс Медикал Сентер Способы диагностики и лечения преэклампсии или эклампсии
WO2004024090A2 (en) 2002-09-12 2004-03-25 The Regents Of The University Of California Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
CN101299962A (zh) 2004-12-15 2008-11-05 貝丝以色列女执事医疗中心 可用于诊断和治疗妊娠并发症的核酸和多肽
ES2371084T3 (es) 2004-12-21 2011-12-27 Yale University Diagnóstico de la preeclampsia.
EP1733762A1 (en) * 2005-05-25 2006-12-20 3M Espe AG Dental composition for detection of carious tissue, detection method
US8263342B2 (en) 2005-10-27 2012-09-11 Yale University Urinary proteomic biomarker patterns in preeclampsia
CA2703254A1 (en) * 2007-10-18 2009-04-23 Jacob Mullerad A diagnostic device for identifying rupture of membrane during pregnancy
US20110065139A1 (en) * 2007-11-27 2011-03-17 Jacob Mullerad diagnostic device for identifying rupture of membrane during pregnancy
CN105021821B (zh) * 2008-10-31 2018-05-11 耶鲁大学 先兆子痫检测和治疗的方法和组合物
CN103012599B (zh) 2012-11-28 2015-04-29 龙岩九健生物芯片技术研究所 一种调节硝酸纤维素硝化取代度的方法
CN116027043A (zh) 2014-04-10 2023-04-28 耶鲁大学 检测错误折叠蛋白的方法和组合物

Also Published As

Publication number Publication date
AU2022291625B2 (en) 2024-09-12
ES2817417T3 (es) 2021-04-07
MX2021006791A (es) 2021-07-15
US11079392B2 (en) 2021-08-03
AU2020244572A1 (en) 2020-11-05
US20190353662A1 (en) 2019-11-21
JP2017518483A (ja) 2017-07-06
WO2015157704A3 (en) 2016-04-28
CA2945058A1 (en) 2015-10-15
WO2015157704A2 (en) 2015-10-15
CN106461644B (zh) 2022-05-13
EP3745127A1 (en) 2020-12-02
US20150293115A1 (en) 2015-10-15
CA3157573A1 (en) 2015-10-15
US20220043001A1 (en) 2022-02-10
AU2015243171A1 (en) 2016-10-27
JP6697394B2 (ja) 2020-05-20
ZA201606987B (en) 2020-01-29
EP3129779B1 (en) 2020-06-03
CN116027043A (zh) 2023-04-28
US11953505B2 (en) 2024-04-09
DK3129779T3 (da) 2020-09-07
AU2015243171B2 (en) 2020-10-15
CN106461644A (zh) 2017-02-22
AU2020244572B2 (en) 2022-12-15
CA2945058C (en) 2022-07-12
EP3129779A2 (en) 2017-02-15
AU2022291625A1 (en) 2023-02-16
US10324094B2 (en) 2019-06-18
EP3745127B1 (en) 2024-08-28

Similar Documents

Publication Publication Date Title
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
BR112016019836A2 (pt) método para analisar uma amostra de um sujeito, dispositivo de diagnóstico para utilização no diagnóstico da endometriose, kit, uso de um biomarcador, e, método para aumentar uma resposta de anticorpos em um sujeito
EP3816303A3 (en) Breast cancer detection kit or device, and method for detecting breast cancer
EP3862439A3 (en) Liver cancer detection kit or device, and detection method
EP3800253A3 (en) Prostate cancer detection kit or device, and detection method
MX2020009021A (es) Ensayos para detectar la presencia o la cantidad de un anticuerpo antifarmaco.
BR112016027475A2 (pt) kit, dispositivo e método para a detecção de câncer pancreático
EP3967769A3 (en) Lung cancer detection kit or device, and detection method
BR112016029583A2 (pt) ?kit ou dispositivo para a detecção de câncer esofágico e método de detecção?
EA201590027A1 (ru) Способы детекции заболеваний или состояний
EP3654036A3 (en) Stomach cancer biomarker and detection method
MX367046B (es) Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
EP3971299A3 (en) Colorectal cancer detection kit or device, and detection method
BR112016028944A2 (pt) kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção
MX2019006005A (es) Metodos para la deteccion de cancer.
NZ722492A (en) Specific biomarker set for non-invasive diagnosis of liver cancer
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
MX2016012278A (es) Deteccion temprana de preeclampsia.
GB201206323D0 (en) Methods and arrays for use in the same
MX2015015015A (es) Metodo para diagnosticar cancer.
MX2015013993A (es) Procedimientos y series para su uso en los mismos.
MX2016007148A (es) Metodos de ensayo de beta-glucano.
MX2019011702A (es) Ensayos de inmunogenicidad mejorados.
WO2014160237A3 (en) Methods of prognosing preeclampsia